Communication

You have full text access to this OnlineOpen article

A new American Joint Committee on Cancer staging system for cutaneous melanoma

  1. Charles M. Balch M.D.1,*,
  2. Antonio C. Buzaid M.D.2,
  3. Michael B. Atkins M.D.3,
  4. Natale Cascinelli M.D.4,
  5. Daniel G. Coit M.D.5,
  6. Irvin D. Fleming M.D.6,
  7. Alan Houghton Jr. M.D.5,
  8. John M. Kirkwood M.D.7,
  9. Martin F. Mihm M.D.8,
  10. Donald L. Morton M.D.9,
  11. Douglas Reintgen M.D.10,
  12. Merrick I. Ross M.D.11,
  13. Arthur Sober M.D.8,
  14. Seng-Jaw Soong Ph.D.12,
  15. John A. Thompson M.D.13,
  16. John F. Thompson M.D.14,
  17. Jeffrey E. Gershenwald M.D.11,
  18. Kelly M. McMasters M.D.15,
  19. for the AJCC Melanoma Staging Committee †

Article first published online: 20 NOV 2000

DOI: 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D

Issue

Cancer

Cancer

Volume 88, Issue 6, pages 1484–1491, 15 March 2000

Additional Information

How to Cite

Balch, C. M., Buzaid, A. C., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Houghton, A., Kirkwood, J. M., Mihm, M. F., Morton, D. L., Reintgen, D., Ross, M. I., Sober, A., Soong, S.-J., Thompson, J. A., Thompson, J. F., Gershenwald, J. E., McMasters, K. M. and for the AJCC Melanoma Staging Committee (2000), A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer, 88: 1484–1491. doi: 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D

Author Information

  1. 1

    American Society of Clinical Oncology, Alexandria, Virginia; John Hopkins Medical Center, Baltimore, Maryland

  2. 2

    Hospital Sirio Libanes, Sao Paolo, Brazil

  3. 3

    Beth Israel Deaconess Medical Center, Boston, Massachusetts

  4. 4

    Istituto Nazionale per lo Studio, Milan, Italy

  5. 5

    Memorial Sloan-Kettering Cancer Center, New York, New York

  6. 6

    Methodist Healthcare Cancer Center, Memphis, Tennessee

  7. 7

    University of Pittsburgh, Pittsburgh, Pennsylvania

  8. 8

    Massachusetts General Hospital, Boston, Massachusetts

  9. 9

    John Wayne Medical Institute, Santa Monica, California

  10. 10

    H. Lee Moffitt Cancer Center, Tampa, Florida

  11. 11

    M. D. Anderson Cancer Center, Houston, Texas

  12. 12

    University of Alabama at Birmingham, Birmingham, Alabama

  13. 13

    University of Washington, Seattle, Washington

  14. 14

    University of Sydney, Sydney, Australia

  15. 15

    University of Louisville, Louisville, Kentucky

  1. †

    The deliberations of this committee were made possible through an unrestricted educational grant provided by Schering Oncology.

*American Society of Clinical Oncology, 225 Reinekers Lane, Suite 650, Alexandria, VA 22314

Publication History

  1. Issue published online: 20 NOV 2000
  2. Article first published online: 20 NOV 2000
  3. Manuscript Accepted: 22 DEC 1999
  4. Manuscript Revised: 14 DEC 1999
  5. Manuscript Received: 4 OCT 1999

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (78K)

The American Joint Committee on Cancer Melanoma Staging Committee proposes major changes to the TNM classification and the stage grouping for cutaneous melanoma. Analyses of prognostic factors by major cooperative groups and cancer centers worldwide contributed data and clinical experience to the simplified and evidence-based recommendations.

View Full Article (HTML) Get PDF (78K)